Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–4 of 4 stories
A recent study explores the resistance mechanisms of trastuzumab deruxtecan in HER2-amplified versus HER2-low breast cancer. Understanding these differences could inform treatment strategies and improve patient outcomes.
Read full storyThe CDC is seeking public comment on a proposed data collection project aimed at evaluating support for young breast cancer survivors and those with metastatic breast cancer. This initiative aligns with the agency's goal to reduce public burden and enhance the utility of government information.
The CDC has established an Advisory Committee on Breast Cancer in Young Women, inviting 15 individuals to contribute to this federal initiative. This committee aims to address the unique challenges faced by young women diagnosed with breast cancer.
New CDC data reveals that thousands died last year due to lack of screening for colon and breast cancer, despite most people being screened. This highlights the critical need for increased awareness and access to screening programs.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.